Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024 Research and Development Obesity, Veru, Wegovy, enobosarm, weight loss

Veru has announced that it has enrolled the first patients into its phase 2b clinical trial of enobosarm, an oral …

News

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024 Research and Development Bayer, Cardiology, cardio, cvd

Bayer and Evotec have announced that they have updated the focus of their collaboration to work on the development of …

News

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024 Research and Development Novartis, PeptiDream, Pharmacy, collaboration, drug discovery, peptides

PeptiDream has announced the expansion of its peptide discovery collaboration with Novartis Pharma AG.

News

Regeneron and Mammoth Biosciences announce CRISPR collaboration

April 26, 2024 Research and Development Pharmacy, Regeneron, crispr, gene editing

Regeneron Pharmaceuticals and Mammoth Biosciences have announced a collaboration for the research, development and commercialisation of in vivo CRISPR-based gene …

News

Prism BioLab and Ono Pharmaceutical enter joint research and licensing agreement

April 25, 2024 Research and Development Oncology, Ono Pharmaceutical, Prism BioLab, research and licensing agreement

Prism BioLab has announced that it has entered into a target-exclusive research and licensing agreement with Ono Pharmaceutical. Under the …

News

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024 Research and Development Cardiology, Sanofi, clinical trial, thrombocytopenia

Sanofi has announced positive results from its phase 3 LUNA 3 study, which assessed rilzabrutinib 400mg twice daily oral treatment …

News

robina-weermeijer-ihfopazzjhm-unsplash_5

Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder

April 22, 2024 Research and Development Kaerus Bioscience, Neurolentech, Neurology, neurodevelopmental disorders, neurology

Neurolentech has announced that it has entered into a technology access partnership with Kaerus Bioscience, with the aim of driving …

News

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024 Research and Development GSK, Reproductive health, clinical trial, gonorrhoea, sexual health

GSK has announced positive results from its phase 3 EAGLE-1 trial for gepotidacin, a potential first-in-class oral antibiotic for the …

News

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024 Research and Development Ear Nose & throat, Eli Lilly, clinical trial, sleep apnoea, tirzepatide

Eli Lilly has announced positive topline results from its SURMOUNT-OSA phase 3 trials which demonstrated that tizepatide injection (10mg or …

News

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024 Research and Development AbbVie, Immunology, Medincell, collaboration

Medincell and AbbVie have announced that they have entered into a collaboration to co-develop and commercialise up to six next-generation …

News

Intra-Cellular Therapies shares phase 3 results for major depressive disorder therapy

April 17, 2024 Research and Development Intra-Cellular Therapies, Neurology, clinical trial, major depressive disorder, mental health

Intra-Cellular Therapies has announced positive topline results from Study 501, which assessed lumateperone 42mg as an adjunctive therapy to antidepressants …

News